Birmingham Capital Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.84M Sell
22,128
-850
-4% -$99.5K 1.08% 27
2026
Q1
$2.76M Hold
22,978
1.17% 28
2025
Q4
$2.42M Sell
22,978
-500
-2% -$46.9K 1.07% 30
2025
Q3
$1.97M Sell
23,478
-4,550
-16% -$375K 0.91% 32
2025
Q2
$2.22M Sell
28,028
-13,862
-33% -$1.1M 0.98% 33
2025
Q1
$3.76M Buy
41,890
+1,160
+3% +$108K 1.41% 26
2024
Q4
$4.05M Sell
40,730
-3,241
-7% -$334K 1.5% 25
2024
Q3
$4.99M Buy
43,971
+2,675
+6% +$318K 1.82% 22
2024
Q2
$5.11M Sell
41,296
-942
-2% -$121K 2% 17
2024
Q1
$5.57M Sell
42,238
-2,175
-5% -$268K 2.05% 16
2023
Q4
$4.84M Sell
44,413
-2,175
-5% -$226K 1.91% 17
2023
Q3
$4.8M Buy
46,588
+5,758
+14% +$621K 1.98% 16
2023
Q2
$4.71M Sell
40,830
-8,493
-17% -$964K 1.97% 17
2023
Q1
$5.25M Sell
49,323
-2,576
-5% -$278K 2.09% 15
2022
Q4
$5.76M Sell
51,899
-1,575
-3% -$161K 2.19% 15
2022
Q3
$4.61M Sell
53,474
-4,875
-8% -$435K 2.04% 16
2022
Q2
$5.32M Sell
58,349
-550
-0.9% -$48.8K 2.12% 16
2022
Q1
$4.83M Sell
58,899
-1,270
-2% -$100K 1.68% 21
2021
Q4
$4.61M Sell
60,169
-500
-0.8% -$39.8K 1.67% 19
2021
Q3
$4.56M Sell
60,669
-700
-1% -$53.2K 1.75% 20
2021
Q2
$4.77M Sell
61,369
-1,976
-3% -$147K 1.75% 19
2021
Q1
$4.66M Buy
63,345
+408
+0.6% +$30.1K 1.74% 17
2020
Q4
$4.91M Sell
62,937
-262
-0.4% -$20K 2.03% 16
2020
Q3
$5M Sell
63,199
-1,021
-2% -$80K 2.27% 15
2020
Q2
$4.74M Buy
64,220
+429
+0.7% +$32.3K 2.31% 14
2020
Q1
$4.68M Sell
63,791
-1,857
-3% -$146K 2.58% 14
2019
Q4
$5.7M Sell
65,648
-1,729
-3% -$142K 2.53% 13
2019
Q3
$5.41M Sell
67,377
-2,201
-3% -$176K 2.49% 14
2019
Q2
$5.57M Sell
69,578
-674
-1% -$51.6K 2.51% 12
2019
Q1
$5.58M Sell
70,252
-1,598
-2% -$120K 2.5% 13
2018
Q4
$5.24M Sell
71,850
-849
-1% -$59.9K 2.55% 12
2018
Q3
$4.92M Sell
72,699
-419
-0.6% -$26.7K 2.03% 16
2018
Q2
$4.24M Sell
73,118
-838
-1% -$47.3K 1.82% 16
2018
Q1
$3.84M Sell
73,956
-2,306
-3% -$125K 1.59% 24
2017
Q4
$4.09M Sell
76,262
-492
-0.6% -$27.3K 1.57% 25
2017
Q3
$4.69M Sell
76,754
-1,096
-1% -$66.4K 1.87% 19
2017
Q2
$4.76M Sell
77,850
-262
-0.3% -$15.9K 1.92% 18
2017
Q1
$4.74M Hold
78,112
1.92% 18
2016
Q4
$4.39M Sell
78,112
-707
-0.9% -$41.4K 1.85% 21
2016
Q3
$4.33M Sell
78,819
-168
-0.2% -$9.82K 1.91% 22
2016
Q2
$4.34M Sell
78,987
-139
-0.2% -$7.4K 1.9% 22
2016
Q1
$4M Sell
79,126
-943
-1% -$46.2K 1.63% 26
2015
Q4
$4.04M Buy
80,069
+2,305
+3% +$116K 1.64% 25
2015
Q3
$3.67M Buy
77,764
+420
+0.5% +$22.3K 1.6% 28
2015
Q2
$4.2M Sell
77,344
-410
-0.5% -$23K 1.64% 27
2015
Q1
$4.26M Sell
77,754
-577
-0.7% -$32.7K 1.62% 26
2014
Q4
$4.25M Sell
78,331
-419
-0.5% -$23.3K 1.64% 27
2014
Q3
$4.45M Sell
78,750
-776
-1% -$43.6K 1.69% 25
2014
Q2
$4.39M Buy
79,526
+178
+0.2% +$9.71K 1.6% 28
2014
Q1
$4.3M Sell
79,348
-2,392
-3% -$124K 1.63% 27
2013
Q4
$3.9M Buy
81,740
+6,424
+9% +$294K 1.47% 31
2013
Q3
$3.42M Sell
75,316
-209
-0.3% -$9.54K 1.36% 32
2013
Q2
$3.35M Buy
+75,525
New +$3.37M 1.39% 31

Other funds holding MRK

Birmingham Capital Management's MRK Position: Q2 2026 in Review

Birmingham Capital Management reduced its Merck (MRK) stake by 3.7% in Q2 2026, selling an estimated $99.5K and leaving 22,128 shares worth $2.84M. The position accounts for 1.08% of the portfolio, ranked #27.

Birmingham Capital Management first reported a position in MRK in Q2 2013 and has held it in 53 quarters since. The position peaked at $5.76M in Q4 2022. 3,817 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Birmingham Capital Management held 22,128 shares of Merck worth $2.84M as of Q2 2026.
  • Birmingham Capital Management sold 850 Merck shares in Q2 2026, an estimated $99.5K.
  • Merck made up 1.08% of Birmingham Capital Management's portfolio in Q2 2026, its #27 holding.
  • Birmingham Capital Management first reported a position in Merck in Q2 2013 and has held it in 53 quarters since.
  • Birmingham Capital Management's Merck position peaked at $5.76M in Q4 2022.
  • 3,817 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Birmingham Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.